Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission | Zendy

Charles S. Chasela | Zendy; Michael G. Hudgens | Zendy; Denise J. Jamieson | Zendy; Dumbani Kayira | Zendy; Mina C. Hosseinipour | Zendy; Athena P. Kourtis | Zendy; Francis Martinson | Zendy; Gerald Tegha | Zendy; R. J. Knight | Zendy; Yusuf Ahmed | Zendy; Deborah Kamwendo | Zendy; Irving Hoffman | Zendy; Sascha Ellington | Zendy; Zebrone Kacheche | Zendy; Alice Soko | Zendy; Jeffrey Wiener | Zendy; Susan A. Fiscus | Zendy; Peter N. Kazembe | Zendy; Innocent Mofolo | Zendy; Maggie Chigwenembe | Zendy; Dorothy Sichali | Zendy; Charles M. van der Horst | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission

Author(s) -

Charles S. Chasela,

Michael G. Hudgens,

Denise J. Jamieson,

Dumbani Kayira,

Mina C. Hosseinipour,

Athena P. Kourtis,

Francis Martinson,

Gerald Tegha,

R. J. Knight,

Yusuf Ahmed,

Deborah Kamwendo,

Irving Hoffman,

Sascha Ellington,

Zebrone Kacheche,

Alice Soko,

Jeffrey Wiener,

Susan A. Fiscus,

Peter N. Kazembe,

Innocent Mofolo,

Maggie Chigwenembe,

Dorothy Sichali,

Charles M. van der Horst

Publication year - 2010

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa0911486

Subject(s) - nevirapine , medicine , regimen , zidovudine , breast feeding , lamivudine , pediatrics , breast milk , immunology , viral load , human immunodeficiency virus (hiv) , viral disease , hepatitis b virus , antiretroviral therapy , biochemistry , virus , chemistry

We evaluated the efficacy of a maternal triple-drug antiretroviral regimen or infant nevirapine prophylaxis for 28 weeks during breast-feeding to reduce postnatal transmission of human immunodeficiency virus type 1 (HIV-1) in Malawi.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research